Safety, PK and Efficacy Study of SJP-0132 in Subjects With Dry Eye Disease

NCT04139122 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

89

Enrollment

INDUSTRY

Sponsor class

Conditions

Dry Eye Disease
Dry Eye Syndrome

Interventions

DRUG: SJP-0132
DRUG: Placebo

Sponsor

Senju Pharmaceutical Co., Ltd.